Mobile

An open-label study to evaluate the utility of the apoptosis imaging biomarker [18F]ML-10 to assess the response to chemotherapy in patients with non Hodgkin's lymphoma

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-019832-11

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

We plan to assess the amount of [18F]ML-10 that is taken up by cancer cells undergoing programmed cell death or apoptosis. We will assess this after chemotherapy treatment in patients with Non Hodgkin's lymphoma, using positron emission tomography (PET) scanning.

Critère d'inclusion

  • Non-Hodgkin's Lymphoma

Liens